Drug Information Association Logo
« Back to Listing

Powering Up Communications: Improving the Information Exchange Between Patients and Industry

Track:
Medical Communication, Medical Writing, and Medical Science Liaison

Day & Time:
June 18, 3:30PM - 5:00PM (Pacific Standard Time)

Session Number:
383

Room Number:
31AB

Level:
Intermediate

Type:
Session

Title:
Powering Up Communications: Improving the Information Exchange Between Patients and Industry

Chair(s):
Rebecca A. Vermeulen, RPh
Senior Director, BioOncology Medical Science Liaisons
Genentech, A Member of the Roche Group, United States

Description:
This session will educate providers in the pharmaceutical, biotechnology, and the device industries on how patients use information to make educated clinical treatment decisions. Attendees will learn how to improve information exchange between patients and industry.

This session has been developed by the DIA Medical Communications, Medical Science Liaison, and Patient Engagement Communities.

Learning Objective(s):
Examine the informational needs of patients who seek support and rationale when reviewing clinical treatment options; Identify the trusted sources patients regularly consult when engaged in the clinical treatment decision making process; Discuss how efficient patient-clinician communication can translate into improved consumer support provided by industry.

Presentation(s) & Speaker(s):
FDA: Empowering Patients with Trusted Resources
Anna M Fine, PharmD, MS
Director, Health Professional Liaison Program, Office of the Commissioner
FDA, United States

EMA Perspective
Sabine Haubenreisser, PhD, MSc
EMA Liaison Official to the US FDA
European Medicines Agency, European Union, United States

Patient Perspective
Stephen Mikita, JD
Patient Advocate
Spinal Muscular Atrophy Foundation, United States